Organisation paid for research Program year 2025 Source: CMS Open Payments

Akron Gastro Research LLC

Neither a doctor nor a teaching hospital

Research payments

$144,678

59 payments

Through program year 2025, Akron Gastro Research LLC is reported as receiving $144,678 in research payments, across 59 payments.

By program year

2 rows
Year Kind Amount Payments
2025 Research $94,778 40
2024 Research $49,900 19

Breakdown

Who paid Research payments · program years 2024–2025
  1. GlaxoSmithKline, LLC. $125,974 56 payments
  2. Chugai Pharmaceutical Co., Ltd. $14,954 2 payments
  3. Caris MPI, Inc. $3,750 1 payment
Studies the money was for Research payments · program years 2024–2025
  1. 17 B-Hydroxysteroid Dehydrogenase Type 13 Minimization for the Treatme $125,974 56 payments
  2. Study of DONQ52 in Active Celiac Disease $14,954 2 payments
  3. The Caris Biorepository Research Protocol $3,750 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record